Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in certain blood-forming cells of the bone marrow.
Chronic myelogenous (or myeloid or myelocytic) leukemia (CML), also known as chronic granulocytic leukemia (CGL), is a cancer of the white blood cells.
Chronic myelogenous leukemia — Comprehensive overview covers causes, treatments and coping with this blood cancer.
Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Leukemia may affect red blood cells, white blood cells, and ...
Reviews in PubMed Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come?
Chronic myelogenous leukemia is a rare myeloproliferative disorder characterized by the excessive development of white blood cells in the spongy tissue ...
Recommendations for the management of chronic myelogenous leukemia (CML) have been developed by an international team of experts (1, 2). These ...
Chronic myelogenous leukemia (CML) is cancer that starts inside bone marrow. This is the soft tissue in the center of bones that helps form all blood cells.
Chronic myelogenous leukemia (CML) is a slow-growing cancer of the bone marrow. It is also sometimes called chronic myeloid, chronic granulocytic, or chronic ...
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a myeloproliferative disorder characterized by increased proliferation of ...